Methylprednisolone Treatment of Friedreich Ataxia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

April 30, 2018

Conditions
Friedreich Ataxia
Interventions
DRUG

Methylprednisolone

Oral tablets of methylprednisolone 8 mg. Subjects will receive a monthly prescription bottle of 25 tablets (standard quantity) and will self-administer 21 tablets over a 28-day dosing cycle.

Trial Locations (1)

19104

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

Friedreich's Ataxia Research Alliance

OTHER

lead

Children's Hospital of Philadelphia

OTHER

NCT02424435 - Methylprednisolone Treatment of Friedreich Ataxia | Biotech Hunter | Biotech Hunter